FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• ALPHAGAN P (BRIMONIDINE TARTRATE)

Snippet

SUPPL AP for ALPHAGAN P (BRIMONIDINE TARTRATE)